There are now hundreds of image-specific AI algorithms across the fields of radiology and cardiology. This is all very exciting. According to a recent study on clinical use of AI in osteoporosis published in the journal Nature, "Applying the AI algorithms in a clinical setting could help primary care providers classify patients with osteoporosis and improve treatment by recommending appropriate exercise programs." Unfortunately, there is a huge caveat. The problem occurs when these algorithms are extended to clinical practice without set standards and requiring massive amounts of data on which to train.

April 13, 2022 – Though research on machine learning use in medical imaging has grown significantly in recent years, improvements in the clinical use of such data remain limited, according to a study published in npj Digital Medicine. Machine learning (ML) is a promising but controversial tool for healthcare providers. Studies suggest heightened enthusiasm around the potential application of ML in clinical settings, but they also note that appropriate regulations must be implemented to ensure that it is effectively implemented. Recent studies have shown that biases within artificial intelligence (AI) algorithms can create health disparities. The current study's authors found that at each step of the research process, potential challenges and biases can be introduced that limit the clinical use of ML in medical imaging.

It never happened--but not for lack of effort. Research teams around the world stepped up to help. The AI community, in particular, rushed to develop software that many believed would allow hospitals to diagnose or triage patients faster, bringing much-needed support to the front lines--in theory. In the end, many hundreds of predictive tools were developed. None of them made a real difference, and some were potentially harmful.

A recent systematic review of a host of scientific manuscripts, conducted by investigators from the University of Cambridge, has found that machine learning models for detecting or diagnosing COVID-19 are not yet suitable compared to standard medical imaging. The research was published in the journal Nature Machine Intelligence. "In the early days of the pandemic, there was such a hunger for information, and some publications were no doubt rushed," James Rudd, a co-author on the study said. "But if you're basing your model on data from a single hospital, it might not work on data from a hospital in the next town over: the data needs to be diverse and ideally international, or else you're setting your machine learning model up to fail when it's tested more widely." For the review, the investigators identified over 2,000 studies published between January and October of 2020, that claimed an ability to diagnose or prognosticate for COVID-19 from chest radiographs (CXR) and computed tomography (CT) images.

In this review article the authors Chenxi Liu, Dian Jiao and Zhe Liu, from Tianjin University, Tianjin, China consider artificial intelligence (AI) aided disease prediction. Artificial intelligence (AI) is widely used in clinical medicine and is increasingly applied to the fields of AI-aided image analysis, AI-aided lesion determination and AI-assisted healthcare management. In this article the authors discuss the emerging applications of AI-related medicine and AI-assisted visualized medicine, including novel diagnostic approaches, metadata analytical methods, and versatile AI-aided treatment applications in preclinical and clinical uses. BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine. As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years.

This repository contains the code for the blog post: Using Microsoft AI to Build a Lung-Disease Prediction Model using Chest X-Ray Images, by Xiaoyong Zhu, George Iordanescu, Ilia Karmanov, data scientists from Microsoft, and Mazen Zawaideh, radiologist resident from University of Washington Medical Center. You should be able to run the code from scratch and get the below result using Azure Machine Learning platform or run it using your own GPU machine. If you are using Azure Machine Learning as the training platform, all the dependencies should be installed. However, if you are trying out in your own environment, you should also install keras-contrib repository to run Keras code. If you are trying out the lung detection algorithm, you need to install a few other additional libraries.

With 6,800 new scientific publications released every day (one every 12 seconds) data mining and horizon scanning is becoming increasingly difficult for medical researchers, which can lead to delayed discoveries in the life science space. One firm believes the solution could lie in bespoke, semi-automated software that combines artificial intelligence approaches, including semantic searching and machine learning, to sift through tens of millions of documents to identify genes, diseases, devices and many more scientific concepts. The semantic platform developed by Cambridge-based technology company SciBite, which is being piloted in partnership with medical research charity LifeArc, enables researchers to gain early insights and uncover information such as novel technologies, new drug targets/biomarkers and rare disease connections. The two firms say that this will improve the ability for researchers to identify emerging mega trends in medical research, with the ultimate aim of accelerating discoveries in the healthcare space. Neal Dunkinson, head of technical sales from SciBite said: "It's almost impossible to keep ahead of the volumes of data being created second to second by the life science industry. Our technology is designed to reduce the time spent mining data by up to 80%, providing researchers with a subset of scientifically-relevant information filtered from the vast amounts of raw data in a rapid, easy-to-interpret manner, allowing them to focus and accelerate their research. As you can imagine, this is a game-changer in the healthcare space where identifying valid new leads is highly-competitive".